Pay in 4 interest-free payments of $5.25 Learn more
Ships within 48 hours · Estimated delivery Oct 22 - Oct 27
Body composition patterns indicating insulin resistance on InBody: Increasing body fat mass, especially centrally Elevated visceral fat level in the abdomen Loss of skeletal muscle mass relative to fat mass Declining leg muscle mass, two-thirds of total muscle is in the legs, which is critical for glucose disposal Reducing BMR despite stable or rising body weight InBodys Segmental Lean Analysis tracks limb muscle changes individually, particularly leg muscle, which plays a crucial role in glucose metabolism and insulin sensitivity
They can help you weigh the potential benefits and risks, taking into account your overall health and existing treatment regimen
This product has not been evaluated or approved by Health Canada, the U.S
Clinical eligibility alone does not create coverage
GHK-Cu, by contrast, has only preclinical (laboratory and animal) evidence and has not been validated in large-scale human trials
